跳至主要内容
临床试验/EUCTR2005-000408-16-SE
EUCTR2005-000408-16-SE进行中(未招募)不适用

Caffeine-mediated modulation of human experimental pain models

Karolinska University Hospital, Huddinge0 个研究点开始时间: 2005年2月11日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Both male and female subjects between the age of 18 and 55 will be included.
  • Subjects should be healthy without on-going long-term medication.
  • All participation will be on voluntary basis and informed written and verbal consent will be acquired from all subjects.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • ·History of any disease that might influence results or cause increased danger or discomfort to the subject. Especially, previous history of cardiac arrhythmias, long-term pain disorder or sleep or mood disorders.
  • ·Consumption of caffeine or xanthine containing beverages and foodstuffs, e.g. tea, chocolate and certain soft drinks in excess of 300 mg/day, corresponding to more than 3-4 cups of coffee/day.
  • ·Any acute signs of illness or infection one week before experiment.
  • ·Overweight, BMI >30.

研究者

发起方
Karolinska University Hospital, Huddinge

相似试验

Caffeine-mediated modulation of human experimental... | 临床试验